SPRB Stock Analysis: Buy, Sell, or Hold?
SPRB - Spruce Biosciences, Inc. Common Stock
$56.50
-0.07 (-0.12%)
▼
5d:
-1.36%
30d:
-14.41%
90d:
-21.96%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When SPRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SPRB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SPRB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$74.11
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$46.02
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SPRB is currently trading at $56.50, which is considered slightly low relative to its 30-day fair value range of $55.42 to $67.27. The stock's valuation (Forward PE: 13.1) is in line with its historical norms (12.3). At these levels, the market is pricing in 2.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $53.75, while resistance sits at $60.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $186.60 (+230.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SPRB is in a strong downtrend. Immediate support is located at $53.75, while resistance sits at $60.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $186.60 (+230.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$55.42 -
$67.27
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 230.3% below Wall St target ($186.60)
- NEUTRAL: Market pricing in 2.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$55.42 -
$67.27
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$53.75
Resistance Level
$60.27
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.14
Wall Street Target
$186.60
(+230.3%)
Revenue Growth (YoY)
-75.9%
Valuation Premium vs History
+2.2% premium
PE vs Historical
13.1 vs 12.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.2%
(market-implied from PE analysis)
1-Year Target
$57.74
(+2%)
2-Year Target
$59.01
(+4%)
3-Year Target
$60.31
(+7%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$56.46
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 09, 2026 7:11 AM ET
Data refreshes hourly during market hours. Next update: 8:11 AM
Data refreshes hourly during market hours. Next update: 8:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 56 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$174 | 63 BUY |
